Chuna Maintenance Therapy: it is conducted every two weeks for a total of 20 weeks for individuals. The technique follows the guidelines of the Society of Chuna Manual Medicine and is based on Chuna Medicine (2.5th edition), which is utilized as a textbook in Korean Medicine colleges.
The treatment is selectively administered based on the clinical judgment of the practitioner.
Study summary
This study is a pragmatic randomized controlled study that assessed 250 subjects complaining of chronic bothersome neck pain with mild discomfort in a 1:1 ratio: chuna maintenance therapy group (125 subjects, 1 time/2 weeks, total 20 weeks) and lifestyle management \& self-exercise group (125 subjects, exercise method education 1 time/4 weeks, total 20 weeks).
Eligibility
Sex
ALL
Min age
19 Years
Max age
70 Years
Healthy volunteers
No
* Inclusion Criteria:
1. Aged 19 or older but under 70.
2. Neck pain with pain duration of 12 months or longer
3. NRS of neck pain over the past month is 2 or more but less than 4
4. Patients who have agreed to trial participation and provided written informed consent
* Exclusion Criteria:
1. Patients diagnosed with serious pathology(s) which may cause neck pain (e.g. spinal metastasis of tumor(s), acute fracture, spinal dislocation)
2. Patients with progressive neurologic deficit or severe neurologic symptoms such as spinal cord injury
3. Patients whose pain is due to soft tissue disease not the spine (e.g. tumors, fibromyalgia, rheumatoid arthritis, gout)
4. Patients with other chronic disease(s) which may interfere with treatment effect, safety, or interpretation of outcome (e.g. stroke and myocardial infarction, kidney disease, diabetic neuropathy, dementia, epilepsy)
5. Patients currently taking steroids, immunosuppressants, medicine for mental illness or other medication(s) that may interfere with study results
6. Pregnant patients or patients with plans of pregnancy or lactating patients
7. Patients within 3 months after cervical surgery
8. Patients with experience of participating in another clinical study within 1 month or plan to participate in another clinical study during the study participation and follow-up period within 6 months from the participation date
9. Patients having difficult to completing the written informed consent
10. Patients who are deemed unsuitable by the researchers
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.